APP and neuroblastoma: MC65 is a genetically engineered human neuroblastoma cell line that conditionally expresses a partial (amino-17 residues + carboxyl-99 residues) fusion of the APP protein with the removal of tetracycline (-TC), where C99 is expressed and cleaved by secretases to generate the Aβ peptide.